Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells.

Cheteh, Emarndeena H; Sarne, Victoria; Ceder, Sophia; Bianchi, Julie; Augsten, Martin; Rundqvist, Helene; Egevad, Lars; Östman, Arne; Wiman, Klas G.

Afiliação

Cheteh EH; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Sarne V; Department of Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
Ceder S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Bianchi J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Augsten M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Rundqvist H; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Egevad L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Östman A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Wiman KG; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.